Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey.
Primary infections caused by Toxoplasma gondii, rubella and cytomegalovirus (CMV) can lead to serious complications in pregnant women. The aim of this study was to determine the seroprevalence of Toxoplasma, rubella and CMV infections through antenatal screening. In this study, the consecutive records of 1652 pregnant women examined between the period March 2004 to January 2006 were included. The results of the antenatal screening for Toxoplasma, rubella and CMV during the first trimester of pregnancy were evaluated. Anti-Toxoplasma, anti-rubella and anti-CMV IgG and IgM antibodies were assayed using an enzyme linked immunosorbent assay method. Of the 1652 pregnant women tested, anti-Toxoplasma IgG antibody was found in 860 (52.1%) of the cases, while 9 (0.54%) of the subjects tested positive for anti-Toxoplasma IgM. Anti-rubella IgG and IgM antibodies were reactive in 1570 (95.0%), and in 9 (0.54%) of the tested women, respectively. Moreover, 1568 (94.9%) of them were found to be positive for anti-CMV IgG, while 7 (0.4%) tested positive for anti-CMV IgM. Consequently, because of the high seropositivity of T. gondii, rubella and CMV in the pregnant women, the country's health authorities should be alerted, and preventive measures should be taken.
Ocak
Sabahattin
S
Department of Infectious Disease and Clinical Microbiology, Mustafa Kemal University, Hatay, Turkey. sabahattinocak@hotmail.com
Zeteroglu
Sahin
S
Ozer
Cahit
C
Dolapcioglu
Kenan
K
Gungoren
Arif
A
D000293:Adolescent; D000328:Adult; D000818:Animals; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000469:parasitology / Q000821:virology; D012409:Rubella / Q000453:epidemiology*; D012412:Rubella virus / Q000302:isolation & purification*; D016036:Seroepidemiologic Studies; D014122:Toxoplasma / Q000302:isolation & purification*; D014123:Toxoplasmosis / Q000453:epidemiology*; D014421:Turkey / Q000453:epidemiology
D007074:Immunoglobulin G; D007075:Immunoglobulin M